A363250 Share Price Performance
₩4,325.00
-4645.00 (-51.78%)
Price ₩4,325.00
Share Pricen/a
Is Genesystem (KOSDAQ:363250) A Risky Investment?
Nov 26
Genesystem Co., Ltd. Stock Price
- 0 Narratives written by author
- 0 Comments on narratives written by author
- 0 Fair Values set on narratives written by author
A363250 Community Narratives
There are no narratives available yet.
There are no community narratives available.
Trending Discussion
Recently Updated Narratives
No recently updated narratives available.
Snowflake Analysis
Genesystem Co., Ltd. Key Details
Last Reported Earnings
Sep 30, 2025
Next Reporting Earnings
n/a
- -1.31k
- -646.48%
- -2,589.31%
- 24.2%
About A363250
- Founded
- 2010
- Employees
- 54
- CEO
- WebsiteView website
Genesystem Co., Ltd., a biotech engineering company, specializes in molecular testing solutions to target on-site testing needs. The company offers PCR systems, multiplex biochips, and PCR reagents. It also provides human pathogen assays, including novel coronavirus (SARS-CoV-2) detection kits, SARS-CoV-2/Flu/RSV simultaneous detection kits, and mycobacterium tuberculosis detection kits; veterinary diagnostics; food safety assays comprising foodborne pathogen detection kits, HALAL food testing kits, and meat species identification kits; and nucleic acid extraction assays, such as extraction kits, extraction buffers, lysis buffers, and gDNA extraction kits. The company was founded in 2010 and is based in Daejeon, South Korea.
